Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Addex Therapeutics Q1 EPS $(1.33) Up From $(1.37) YoY, Sales $78.93K Down From $268.83K YoY

Author: Benzinga Newsdesk | June 19, 2025 02:39am
Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of $(1.33) per share. This is a 2.92 percent increase over losses of $(1.37) per share from the same period last year. The company reported $78.93 thousand in sales this quarter. This is a 70.64 percent decrease over sales of $268.83 thousand the same period last year.

Posted In: ADXN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist